Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive

3 days ago 8

Attiya Zainib

Tue, March 31, 2026 astatine 7:18 AM CDT 3 min read

Ariel Investments, an concern absorption company, released its "Ariel Global Fund" fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Ariel Global Fund delivered coagulated results successful 2025, rising +23.30% for the twelvemonth and outperforming some the MSCI ACWI and MSCI ACWI Value indices, though it lagged benchmarks successful the 4th fourth with a +2.88% instrumentality versus +3.29% and +3.66%, respectively, for the indexes. The 4th unfolded against a constructive planetary backdrop, arsenic moderating inflation, easing fiscal conditions, and resilient firm net supported equities, with spot led by U.S. mega-cap exertion stocks, improving conditions successful Europe and Japan, and a beardown full-year rebound successful China. Performance was driven chiefly by banal selection, with gains successful financials and accusation exertion offset by weakness successful user discretionary and healthcare holdings, portion respective idiosyncratic positions faced short-term pressures from higher costs, restructuring charges, oregon softer demand. Looking ahead, absorption remains optimistic connected planetary equities, citing improving firm fundamentals, supportive argumentation environments, and charismatic valuations comparative to maturation prospects, portion emphasizing that expanding marketplace dispersion and a broadening of enactment beyond U.S. mega-cap stocks make a favorable situation for active, bottom-up banal enactment focused connected companies with beardown equilibrium sheets, durable earnings, and semipermanent structural maturation drivers. In addition, you tin cheque the Fund’s apical 5 holdings for its champion picks for 2025.

In its fourth-quarter 2025 capitalist letter, Ariel Investments' Global Fund highlighted stocks similar Fresenius Medical Care AG (NYSE:FMS). Fresenius Medical Care AG (NYSE:FMS) is simply a planetary healthcare institution specializing successful dialysis products and services, providing life-sustaining attraction to patients with chronic kidney nonaccomplishment worldwide. The one-month instrumentality of Fresenius Medical Care AG (NYSE:FMS) was -5.16% portion its shares traded betwixt $20.95 and $30.46 implicit the past 52 weeks. On March 30, 2026, Fresenius Medical Care AG (NYSE:FMS) banal closed astatine astir $22.21 per share, with a marketplace capitalization of astir $12.80 billion.

Ariel Investments' Global Fund stated the pursuing regarding Fresenius Medical Care AG (NYSE:FMS) in its Q4 2025 capitalist letter:

"Fresenius Medical Care AG (NYSE:FMS), the Germany-based planetary person successful kidney dialysis services and products, traded little connected mixed quarterly results. While the institution delivered integrated maturation crossed each segments, net were impacted by continued restructuring and portfolio optimization costs. With profitability trending higher and beardown currency procreation supporting equilibrium expanse deleveraging, we presumption Fresenius arsenic attractively positioned from a risk/reward perspective."

Read Entire Article